Skip to content

Effect of Ayurveda purification therapy over obesity related problems

Virechana karma efficacy in medoroga vis a vis metabolic syndrome An experimental and clinical evaluation

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014654
Enrollment
20
Registered
2018-06-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Central obesity with hyperglycemia and dyslipidemia who are not taking any medication

Interventions

Intervention1: Virechana karma: Trivut lehya Operculatum terpentum 80 gram single dosage on last day i.e. 14 the day Intervention2: Deepana Pachana: Trikatu churna 3gram tid admistered oraly for first

Sponsors

SDM College of Ayurveda Hassan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are fit for Virechana karma with Madhyama kostha. Patients diagnosed as Metabolic Syndrome characterized by: Central obesity defined as waist circumference >= 90 cm for men and >= 80cm for women or Obesity ranges from class I and II i.e. BMI from 30-39.9 kg/m2 Fasting blood sugar ranges from 100-180 mg/dl without any medications. Raised triglycerides ranges from150mg/dl - 499 mg/dl

Exclusion criteria

Exclusion criteria: Patients present with Type 1 diabetes, Gestational diabetes, uncontrolled diabetes mellitus patients, uncontrolled hypertension and Cardio Vascular Diseases.

Design outcomes

Primary

MeasureTime frame
Effect of over body weight, waist hip circumference, body mass index and lipid levelTimepoint: 14th day of therapy

Secondary

MeasureTime frame
Relation with various demographic factors such as region, prakruti of patients, with panchkarma and obesityTimepoint: 30th day

Countries

India

Contacts

Public ContactAshutosh Chaturvedi

SDM College of Ayurveda Hassan

ashvinipanchakarma@gmail.com9448705660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026